Why is Arvee Laborat. falling/rising?

As of 24-Sep, Arvee Laboratories (India) Ltd is experiencing a price increase, currently at 175.20, reflecting a rise of 3.08 or 1.79%. The stock has outperformed its sector by 2.28% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there is a notable decline in investor participation, with delivery volume dropping by 53.61% against the 5-day average. While the company has a low debt-to-equity ratio and is primarily held by promoters, it faces challenges such as poor long-term growth, indicated by a mere 1.80% annual growth rate in operating profit over the last five years. Additionally, negative results from June 25 show a significant decline in net sales and profit before tax, contributing to a perception of the stock being overvalued relative to its peers. In the broader market context, Arvee Laboratories has shown a positive short-term return of 1.95% over the past week, contrasting with a decline of 1.08% in the Sensex during the same period. Over the past month, the stock has increased by 8.95%, while the benchmark has only risen by 0.75%. Despite these short-term gains, the stock's year-to-date performance is relatively modest at 0.82%, underperforming the Sensex's 5.97% increase. The stock's long-term performance remains concerning, with a 5.55% decline over the past year, indicating that while it may be rising in the short term, underlying issues could impact its future performance.